Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Early countermeasures against ineffective therapies

26.02.2018

In the joint PANTHER project, Fraunhofer MEVIS is working on using CT images more effectively in tumor therapy follow-ups.

What effect does a particular cancer medicine or radiation therapy have on patients? To find out, physicians use CT images to determine whether a tumor’s size changes during the course of treatment. In the PANTHER project, a joint team of experts aims at gaining further valuable information from these images.


Radiomics discovers relationships between image features and clinical data. The “heatmap” groups patients with similar features and represents them in areas of the same color.

© Photo Fraunhofer MEVIS

In the future, doctors will be able to find out at an early stage whether a cancer treatment is effective or should be changed. The Fraunhofer Institute for Medical Image Computing MEVIS, with its branches in Bremen and Lübeck, is an essential project partner. This spring, the project team will present the interim results from the first project period.

Physicians monitor the course of tumor therapy by observing the general condition of their patients, analyzing lab values from blood tests, and taking regular CT images of the affected organs. Until now, doctors have only used the images to monitor tumor size development. Has the tumor shrunk as a result of radiation or chemotherapy or has it grown further, making a change in therapy, such as choosing an alternative medication, seem reasonable?

This is where the joint PANTHER project comes into play. “So far, size development of a tumor is the most important criterion in evaluating CT images,” says Fraunhofer MEVIS computer scientist Jan Hendrik Moltz.

“Yet, there is so much more information hidden in these images that has barely been used.” In addition to size progression, the images also show how and to which degree the shape of the ulcer has changed. They can give details about the texture and nature of the tumor, whether it consists of different types of tissues, and whether its composition changes during the course of therapy.

Much of this information is invisible to the naked eye, which causes difficulties. “To be able to recognize and in particular quantify these features, physicians need computer assistance,” says Moltz. “This is precisely the goal of PANTHER.”

Since October 2016, the Federal Ministry of Education and Research has sponsored the joint “Patient-oriented oncological therapy assistance” project with an overall funding around 2.8 million euro. In addition to Fraunhofer MEVIS, further participants include the Medical Center of the University of Munich, MeVis BreastCare GmbH & Co.KG, as well as project coordinator Siemens Healthcare GmbH.

In the first phase, radiologists of the Medical Center of the University of Munich compiled large amounts of CT image data of colon cancer and lymphoma patients. The clinicians segmented relevant structures in the images using a web tool, making the size and shape of the tumors and organs in the images recognizable and measurable. At a later stage, an automatic algorithm will perform the segmentation instead.

The oncologists in Munich provided extensive data material on patients’ response to a therapy and how their blood values changed during the course of treatment. Experts want to align particular features of the CT images with the data, such as changes in the shape and texture of the tumor during therapy. Comprehensive statistical analyses will reveal possible reliable correlations between image and therapy data. “Ideally, the CT images would help assess at an early stage whether or not a particular therapy is successful,” says Julian Holch, an oncologist at the Medical Center of the University of Munich.

Soon, the PANTHER team will be preparing for a mid-term review. “We have already collected a large share of the data and developed essential parts of the software, for example, for the automatic segmentation of the spleen,” explains Moltz. “We have also identified features in the CT images that we wish to evaluate with statistical analyses.” For patients with colon cancer, change in liver metastases could be a possible indicator of therapy success. For lymphoma patients, changes in spleen shape could deliver clues concerning the effect of therapy.

“By the end of the project in 2019, the potential benefit of our approach for medicine should be clear,” says Jan Hendrik Moltz. “The next step would be the development of a computer-based expert system that supports doctors in choosing the best therapy.”

The joint project is an example of a new approach in medicine called radiomics, a mix of radiology and genomics. Elaborate algorithms could help extract additional information from radiological images and correlate them with data from clinics and labs. The goal is to develop therapies that target specific patients or cancer types. “Radiomics has the potential of making medicine more efficient and thus produce benefits for the patients,” says Horst Hahn, one of Fraunhofer MEVIS’ directors. “This way, we can gain profound analysis of diseases that can help figure out which patients will respond to what therapy methods.”

Weitere Informationen:

https://www.mevis.fraunhofer.de/en/press-and-scicom/press-release/2018/early-cou...

Bianka Hofmann | Fraunhofer MEVIS - Institut für Bildgestützte Medizin

Further reports about: Bildgestützte Medizin CT CT images colon cancer lymphoma lymphoma patients

More articles from Medical Engineering:

nachricht Rutgers researchers develop automated robotic device for faster blood testing
14.06.2018 | Rutgers University

nachricht Speech comprehension with a cochlear implant
04.06.2018 | Universität zu Lübeck

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: AchemAsia 2019 will take place in Shanghai

Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.

Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...

Im Focus: First real-time test of Li-Fi utilization for the industrial Internet of Things

The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.

Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.

Im Focus: Sharp images with flexible fibers

An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.

Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...

Im Focus: Photoexcited graphene puzzle solved

A boost for graphene-based light detectors

Light detection and control lies at the heart of many modern device applications, such as smartphone cameras. Using graphene as a light-sensitive material for...

Im Focus: Water is not the same as water

Water molecules exist in two different forms with almost identical physical properties. For the first time, researchers have succeeded in separating the two forms to show that they can exhibit different chemical reactivities. These results were reported by researchers from the University of Basel and their colleagues in Hamburg in the scientific journal Nature Communications.

From a chemical perspective, water is a molecule in which a single oxygen atom is linked to two hydrogen atoms. It is less well known that water exists in two...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Munich conference on asteroid detection, tracking and defense

13.06.2018 | Event News

2nd International Baltic Earth Conference in Denmark: “The Baltic Sea region in Transition”

08.06.2018 | Event News

ISEKI_Food 2018: Conference with Holistic View of Food Production

05.06.2018 | Event News

 
Latest News

A sprinkle of platinum nanoparticles onto graphene makes brain probes more sensitive

15.06.2018 | Materials Sciences

100 % Organic Farming in Bhutan – a Realistic Target?

15.06.2018 | Ecology, The Environment and Conservation

Perovskite-silicon solar cell research collaboration hits 25.2% efficiency

15.06.2018 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>